Skip to main content

B-Raf proto-oncogene, serine/threonine kinase

The BRAF gene provides instructions for making a protein that helps transmit chemical signals from outside the cell to the cell's nucleus. This protein is part of a signaling pathway known as the RAS/MAPK pathway, which controls several important cell functions. Specifically, the RAS/MAPK pathway regulates the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), cell movement (migration), and the self-destruction of cells (apoptosis). Chemical signaling through this pathway is essential for normal development before birth.

Video picks for Genes
Video library

Normal function

The BRAF gene provides instructions for making a protein that helps transmit chemical signals from outside the cell to the cell's nucleus. This protein is part of a signaling pathway known as the RAS/MAPK pathway, which controls several important cell functions. Specifically, the RAS/MAPK pathway regulates the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), cell movement (migration), and the self-destruction of cells (apoptosis). Chemical signaling through this pathway is essential for normal development before birth.

The BRAF gene belongs to a class of genes known as oncogenes. When mutated, oncogenes have the potential to cause normal cells to become cancerous.

Conditions referring to this gene or chromosome

Other names

94 kDa B-raf protein

B-raf 1

B-Raf proto-oncogene serine/threonine-protein kinase

BRAF1

BRAF1_HUMAN

Murine sarcoma viral (v-raf) oncogene homolog B1

p94

RAFB1

v-raf murine sarcoma viral oncogene homolog B

Related patient information and medicines

Primary liver cancer

Patient information leaflet

Primary liver cancer

For example, if yellowing (jaundice) is severe, it... Chemotherapy Chemotherapy Chemotherapy is a treatment which uses anti-cancer medicines to kill cancer cells, or to stop them from multiplying. There are new medicines being developed for the treatment of liver cancer. For example, sorafenib is a type of medicine called a multi-targeted kinase.

Mouth cancer

Patient information leaflet

Mouth cancer

Diagnosing mouth cancer Your healthcare professional may suspect mouth cancer if you have a lesion in your mouth (such as a sore, an ulcer or a lump) which has not healed for 3 wee... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or.

Pompholyx

Patient information leaflet

Pompholyx

Pompholyx is a type of eczema where there are itchy blisters on the hands and feet, followed by inflamed and dry skin. The condition is usually long-term, with symptoms that come and go at various times. The first step in managing pompholyx is to identify and avoid things that make it worse. Treatment includes creams and ointments to reduce.

Glycogen storage disorders

Patient information leaflet

Glycogen storage disorders

Glycogen storage disorders are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. Symptoms include weakness, tiredness and low blood sugar levels. Most people with a glycogen storage disorder respond.

Muscular dystrophy

Patient information leaflet

Muscular dystrophy

Muscular dystrophy is an inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, ranging from very mild to severe. If muscular dystrophy is suspected, tests can help to make an accurate diagnosis. Genes are the 'control centre' of each cell in the body, including.

Mastocytosis and mast cell disorders

Patient information leaflet

Mastocytosis and mast cell disorders

A mast cell is a type of white blood cell. If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on the immune system (suc... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 28 May 2021 | Latest version
  • 1 Jul 2018 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.